Evidence map›Paper›PMID 36918588›Full record

ArticleNature communications2023

Executioner caspases restrict mitochondrial RNA-driven Type I IFN induction during chemotherapy-induced apoptosis.

Shane T Killarney, Rachel Washart, Ryan S Soderquist, Jacob P Hoj, Jamie Lebhar, Kevin H Lin, Kris C Wood

Open access · goldFull text read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Structural and molecular principles of DAMP biology.Nature structural & molecular biology · 2026
    Review
  5. MTCH2 promotes BAX and BAK self-assembly and apoptotic pore growth.Nature structural & molecular biology · 2026
    Article
  6. Review
  7. CypD Dependent mPTP Opening Is Crucial for Oxidized Mitochondrial DNA Release in Ferroptosis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Regulation of inflammatory processes by caspases.Nature reviews. Molecular cell biology · 2025
    Review
  14. Mitochondrial metabolism and cancer therapeutic innovation.Signal transduction and targeted therapy · 2025
    Review
  15. cGAS/STING-Independent Induction of Type I Interferon by Inhibitors of the Histone Methylase KDM5B.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Mitochondria and cell death.Nature cell biology · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shane T KillarneyDepartment of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.ORCID 0000-0002-8471-6641
Rachel WashartDepartment of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.ORCID 0000-0001-6431-0188
Ryan S SoderquistDepartment of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.
Jacob P HojDepartment of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.ORCID 0000-0003-3298-3083
Jamie LebharDepartment of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.
Kevin H LinDepartment of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA.
Kris C WoodDepartment of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA. kris.wood@duke.edu.ORCID 0000-0002-5887-2253
Duke University · USBrigham and Women's Hospital · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007171 · NIGMS · DUKE UNIVERSITY · PI KONTOS, CHRISTOPHER D · 1985 to 2021
$31.2M
Medical Scientist Training Program Training GrantT32GM145449 · NIGMS · DUKE UNIVERSITY · PI Christopher D Kontos · 2022 to 2026
$6.6M
Selectively targeting apoptosis in PIK3CA mutant colorectal cancersR01CA207083 · NCI · DUKE UNIVERSITY · PI WOOD, KRIS C. · 2016 to 2020
$1.8M
Mechanism-based targeting of unique survival signaling in residual tumorsR01CA263593 · NCI · DUKE UNIVERSITY · PI Kris C. Wood · 2022 to 2026
$1.7M
Uncovering actionable signaling pathways required for solid tumor brain metastasisK00CA245732 · NCI · DUKE UNIVERSITY · PI HOJ, JACOB PETER · 2020 to 2022
$255k
Exploring BCL-XL addiction in pancreatic ductal adenocarcinomaF32CA206234 · NCI · DUKE UNIVERSITY · PI SODERQUIST, RYAN · 2016 to 2018
$173k
Designing durable apoptosis-targeting therapies for acute myeloid leukemiaF30CA206348 · NCI · DUKE UNIVERSITY · PI LIN, KEVIN HAO-YU · 2016 to 2017
$78k
NCI NIH HHS F30 CA206348NCI NIH HHS F32 CA206234NCI NIH HHS K00 CA245732NCI NIH HHS R01 CA207083NCI NIH HHS R01 CA263593NIGMS NIH HHS T32 GM007171NIGMS NIH HHS T32 GM145449
6 · The paper itself

Abstract

During apoptosis, mitochondrial outer membrane permeabilization (MOMP) enables certain mitochondrial matrix macromolecules to escape into the cytosol. However, the fate of mitochondrial RNA (mtRNA) during apoptosis is unknown. Here, we demonstrate that MOMP results in the cytoplasmic release of mtRNA and that executioner caspases-3 and -7 (casp3/7) prevent cytoplasmic mtRNA from triggering inflammatory signaling. In the setting of genetic or pharmacological casp3/7 inhibition, apoptotic insults result in mtRNA activation of the MDA5/MAVS/IRF3 pathway to drive Type I interferon (IFN) signaling. This pathway is sufficient to activate tumor-intrinsic Type I IFN signaling in immunologically cold cancer models that lack an intact cGAS/STING signaling pathway, promote CD8

Indexed as

Antineoplastic AgentsInterferon Type IApoptosisCaspase 3CaspasesNucleotidyltransferasesRNA, MitochondrialAntineoplastic AgentsCaspase 3CaspasesInterferon Type INucleotidyltransferasesRNA, Mitochondrial

Identifiers

PMID36918588
PMCPMC10015073
OpenAlexW4324303305

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read1
measurements read78
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.